POLAREAN Company Profile
✉ Email this page to a colleague
What is the competitive landscape for POLAREAN, and when can generic versions of POLAREAN drugs launch?
POLAREAN has one approved drug.
There are two US patents protecting POLAREAN drugs.
There are six patent family members on POLAREAN drugs in six countries.
Summary for POLAREAN
| International Patents: | 6 |
| US Patents: | 2 |
| Tradenames: | 1 |
| Ingredients: | 1 |
| NDAs: | 1 |
Drugs and US Patents for POLAREAN
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Polarean | XENOVIEW | xenon xe-129 hyperpolarized | GAS;INHALATION | 214375-001 | Dec 23, 2022 | RX | Yes | Yes | 11,052,161 | ⤷ Subscribe | Y | ⤷ Subscribe | |||
| Polarean | XENOVIEW | xenon xe-129 hyperpolarized | GAS;INHALATION | 214375-001 | Dec 23, 2022 | RX | Yes | Yes | ⤷ Subscribe | ⤷ Subscribe | |||||
| Polarean | XENOVIEW | xenon xe-129 hyperpolarized | GAS;INHALATION | 214375-001 | Dec 23, 2022 | RX | Yes | Yes | 10,583,205 | ⤷ Subscribe | Y | ⤷ Subscribe | |||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
International Patents for POLAREAN Drugs
| Country | Patent Number | Estimated Expiration |
|---|---|---|
| European Patent Office | 3107583 | ⤷ Subscribe |
| Canada | 2940109 | ⤷ Subscribe |
| Australia | 2015218883 | ⤷ Subscribe |
| Hungary | E045999 | ⤷ Subscribe |
| World Intellectual Property Organization (WIPO) | 2015127208 | ⤷ Subscribe |
| >Country | >Patent Number | >Estimated Expiration |
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.
Here is a list of applicants with similar names.
